Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment-Results From CURE
- PMID: 37604426
- DOI: 10.1016/j.jaip.2023.08.020
Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment-Results From CURE
Abstract
Background: Patients with chronic spontaneous urticaria (CSU) have spontaneous wheals (W), angioedema (AE), or both, for longer than 6 weeks. Clinical differences between patients with standalone W, standalone AE, and W and AE (W+AE) remain incompletely understood.
Objective: To compare W, AE, and W+AE CSU patients regarding demographics, disease characteristics, comorbidities, disease burden, and treatment response.
Methods: Baseline data from 3,698 CSU patients in the ongoing, prospective, international, multicenter, observational Chronic Urticaria REgistry (CURE) were analyzed (data cut: September 2022).
Results: Across all CSU patients, 59%, 36%, and 5% had W+AE, W, and AE, respectively. The W+AE patients, compared with W and AE patients, showed the lowest male-to-female ratio (0.33), higher rates of concomitant psychiatric disease (17% vs 11% vs 6%, respectively), autoimmune disease (13% vs 7% vs 9%, respectively), and nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity (9% vs 5% vs 2%, respectively) and the highest disease impact. The W patients, compared with W+AE and AE patients, showed the lowest rates of concomitant hypertension (15% vs 21% vs 40%, respectively) and obesity (11% vs 16% vs 17%, respectively), the highest rate of concomitant inducible urticaria (24% vs 22% vs 6%, respectively), and shorter W duration. The AE patients, compared with W+AE and W patients, were older at disease onset, showed longer AE duration, and the best response to increased doses of H1-antihistamines (58% vs 24% vs 31%, respectively) and omalizumab (92% vs 67% vs 60%, respectively).
Conclusions: Our findings provide a better understanding of CSU phenotypes and may guide patient care and research efforts that aim to link them to pathogenic drivers.
Keywords: Angioedema; CSU; CURE registry; Chronic spontaneous urticaria; Recurrent; Without wheals.
Copyright © 2023. Published by Elsevier Inc.
Similar articles
-
Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response.Pediatr Allergy Immunol. 2023 Feb;34(2):e13925. doi: 10.1111/pai.13925. Pediatr Allergy Immunol. 2023. PMID: 36825740
-
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31. Allergy. 2016. PMID: 27010957 Clinical Trial.
-
Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria.Int Arch Allergy Immunol. 2024;185(3):260-266. doi: 10.1159/000535414. Epub 2023 Dec 19. Int Arch Allergy Immunol. 2024. PMID: 38113870
-
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.Eur J Dermatol. 2017 Feb 1;27(1):10-19. doi: 10.1684/ejd.2016.2905. Eur J Dermatol. 2017. PMID: 27882879 Review.
-
Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.Curr Pharm Biotechnol. 2021;22(1):32-45. doi: 10.2174/1389201021666200630140137. Curr Pharm Biotechnol. 2021. PMID: 32603278 Review.
Cited by
-
The Epidemiology of Chronic Urticaria in Cape Town, South Africa: A Review of Two Tertiary Referral Centers.Allergy. 2025 Aug;80(8):2405-2409. doi: 10.1111/all.16547. Epub 2025 Mar 31. Allergy. 2025. PMID: 40162584 Free PMC article. No abstract available.
-
Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?World Allergy Organ J. 2024 Aug 5;17(8):100943. doi: 10.1016/j.waojou.2024.100943. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39193419 Free PMC article.
-
Global productivity, international collaborations, and research trends in chronic spontaneous urticaria: A bibliometric overview.J Allergy Clin Immunol Glob. 2025 Mar 18;4(2):100455. doi: 10.1016/j.jacig.2025.100455. eCollection 2025 May. J Allergy Clin Immunol Glob. 2025. PMID: 40231228 Free PMC article.
-
[What are the main symptoms of urticaria and how are they systematically recorded?].Dermatologie (Heidelb). 2024 Apr;75(4):274-280. doi: 10.1007/s00105-024-05304-z. Epub 2024 Feb 29. Dermatologie (Heidelb). 2024. PMID: 38424150 Review. German.
-
Reply.J Allergy Clin Immunol Glob. 2024 Dec 19;4(2):100388. doi: 10.1016/j.jacig.2024.100388. eCollection 2025 May. J Allergy Clin Immunol Glob. 2024. PMID: 39896206 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical